S101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)
Maurizio Martelli, Luca Ceriani, Emanuele Zucca, Irina Kryachok et autres
Topic: 19. Aggressive Non-Hodgkin lymphoma - Clinical Background: Primary mediastinal B-cell lymphoma (PMBCL) has a good prognosis if remission is rapidly achieved with dose-intensive immunochemotherapy. In these patients, mediastinal radiotherapy (RT) may consolidate responses; however, it increases the risk of second malignancies …
it, ch, ua, pl, cn, ca, no, gb, se, cz, de, pt, us (code pays fourni par la source)
3 citations
HemaSphere